BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 28939956)

  • 1. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
    Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
    Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis.
    Andò G; Gragnano F; Calabrò P; Valgimigli M
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E518-E526. PubMed ID: 30244540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.
    Andò G; Cortese B; Frigoli E; Gagnor A; Garducci S; Briguori C; Rubartelli P; Calabrò P; Valgimigli M;
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):950-7. PubMed ID: 25854692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vascular access on acute kidney injury after percutaneous coronary intervention.
    Andò G; Costa F; Trio O; Oreto G; Valgimigli M
    Cardiovasc Revasc Med; 2016; 17(5):333-8. PubMed ID: 27050627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of femoral or radial approach on acute renal injury induced by repeated contrast medium in patients with coronary heart disease].
    Li P; Kang Y; Wang ZF; Gu CH; Ai GN; Liu YF; Xu P; Wang XZ; Zhao X; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Dec; 48(12):1053-1059. PubMed ID: 33355750
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Radial Access on Contrast-Induced Acute Kidney Injury in Patients With Coronary Artery Bypass Grafts.
    Stephan T; Felbel D; Rattka M; Rottbauer W; Markovic S
    Cardiovasc Revasc Med; 2022 Mar; 36():123-131. PubMed ID: 33992588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Access Site Choice on Acute Kidney Injury After Percutaneous Coronary Intervention.
    Pancholy MS; Skelding K; Scott T; Blankenship J; Pancholy SB
    Am J Cardiol; 2017 Dec; 120(12):2141-2145. PubMed ID: 29100589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.
    Schönenberger E; Martus P; Bosserdt M; Zimmermann E; Tauber R; Laule M; Dewey M
    Radiology; 2019 Sep; 292(3):664-672. PubMed ID: 31264950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention).
    Michael TT; Alomar M; Papayannis A; Mogabgab O; Patel VG; Rangan BV; Luna M; Hastings JL; Grodin J; Abdullah S; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1138-44. PubMed ID: 24139930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Ferrante G; Rao SV; Jüni P; Da Costa BR; Reimers B; Condorelli G; Anzuini A; Jolly SS; Bertrand OF; Krucoff MW; Windecker S; Valgimigli M
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1419-34. PubMed ID: 27372195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of coronary interventions in a single centre and comparison of specific differences between radial and femoral access.
    Rychlik J; Hornacek I; Tejc M; Petrikovits E; Klimsa Z
    Acta Cardiol; 2019 Aug; 74(4):325-330. PubMed ID: 30193077
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery.
    Jiang W; Yu J; Xu J; Shen B; Wang Y; Luo Z; Wang C; Ding X; Teng J
    BMC Cardiovasc Disord; 2018 Oct; 18(1):191. PubMed ID: 30290766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.